Mark Theo Bloch
ORCID：0000-0002-1143-5013
发表论文 97 篇 · 总被引 4491 次 · h-index 29
代表论文
- Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study (2018 · The Lancet HIV · 被引 539)
- Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials (2018 · The Lancet · 被引 391)
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial (2018 · The Lancet HIV · 被引 150)
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial (2019 · The Lancet HIV · 被引 101)
- Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy (2017 · AIDS · 被引 81)
- Managing HIV‐associated inflammation and ageing in the era of modern ART (2020 · HIV Medicine · 被引 67)